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Reduction in unplanned hospitalizations
associated with a physician focused
intervention to reduce potentially
inappropriate medication use among older
adults: a population-based cohort study
M. Alcusky1*, R. B. Thomas2, N. Jafari3, S. W. Keith4, A. Kee2, S. Del Canale5, M. Lombardi5 and V. Maio2*
Abstract
Background: A multimodal general practitioner-focused intervention in the Local Health Authority (LHA) of Parma,
Italy, substantially reduced the prevalence of potentially inappropriate medication (PIM) use among older adults.
Our objective was to estimate changes in hospitalization rates associated with the Parma LHA quality improvement
initiative that reduced PIM use.
Methods: This population-based longitudinal cohort study was conducted among older residents (> 65 years) using
the Parma LHA administrative healthcare database. Crude and adjusted unplanned hospitalization rates were estimated
in 3 periods (pre-intervention: 2005–2008, intervention: 2009–2010, post-intervention: 2011–2014). Multivariable
negative binomial models estimated trends in quarterly hospitalization rates among individuals at risk during each
period using a piecewise linear spline for time, adjusted for time-dependent and time-fixed covariates.
Results: The pre-intervention, intervention, and post-intervention periods included 117,061, 107,347, and 121,871 older
adults and had crude hospitalization rates of 146.2 (95% CI: 142.2–150.3), 146.8 (95% CI: 143.6–150.0), and 140.8 (95% CI:
136.9–144.7) per 1000 persons per year, respectively. The adjusted pre-intervention hospitalization rate was declining
by 0.7% per quarter (IRR = 0.993; 95% CI: 0.991–0.995). The hospitalization rate declined more than twice as fast during
the intervention period (1.8% per quarter, IRR = 0.982; 95% CI: 0.979–0.985) and was nearly constant post-intervention
(IRR: 0.999; 95% CI: 0.997–1.001). Contrasting model predictions for the intervention period (Q1 2009 to Q4 2010), the
intervention was associated with 1481 avoided hospitalizations.
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Conclusion: In a large population of older adults, a multimodal general practitioner-focused intervention to decrease
PIM use was associated with a decline in the unplanned hospitalization rate. Such interventions to reduce high risk
medication use among older adults warrant consideration by health systems seeking to improve health outcomes and
reduce high-cost acute care utilization.
Keywords: Prescribing, Hospitalizations, Older adults
Introduction
The danger of potentially inappropriate medications (PIMs)
for older adults has been well-known to healthcare practi-
tioners for the better part of the past few decades [1, 2]. The
risks posed by PIMs are magnified as the number of medica-
tions older adults are exposed to rises [3], increasing the op-
portunity for adverse events related to drug interactions or
errors in use [4]. The use of PIMs in older adults leads to
worse clinical outcomes [5–8], higher healthcare resource
utilization, such as increased hospitalization [9–11], and
higher costs to the healthcare system as a whole [12, 13].
Some of the most common side effects of PIM use in older
adults include falls, orthostasis, constipation, and acute kid-
ney injury [14].
Reduction of PIM use has become a priority of health-
care systems. Many interventions to reduce PIM use in
older adults have been piloted and implemented, and
studies have shown them to be effective [15–17].
Though PIM use in older adults is associated with in-
creasing hospitalizations [9–11], there is limited evi-
dence on the effect that interventions to decrease PIM
use in the older adult population have on hospitalization
rates. A recent Cochrane review reported mixed results
across five studies examining the effect of multifaceted
pharmaceutical care-based interventions to improve
medication use in older adults on hospitalizations [16].
Interventions varied from the use of explicit criteria
when assessing patients to the inclusion of a pharmacist
on the care team [16]. However, prior studies have gen-
erally been small and have not evaluated interventions
to reduce PIM use targeted at the level of an entire local
healthcare system, as in the current study.
We previously conducted a physician-focused, multimodal,
quality improvement initiative to reduce PIM exposure in
the older adult population of the Local Health Authority
(LHA) of Parma, Italy [15, 18]. The initiative involved devel-
opment of an Italian-focused PIMs list by an expert panel,
multimodal education and dissemination of the list targeting
all 303 general practitioners (GPs) in Parma LHA, and feed-
back on performance (i.e., PIM prescribing rates) to GPs over
time. The intervention focused on GPs because they serve as
gatekeepers and the primary managers of care for patients in
Italy, and GPs have historically prescribed PIMs more often
than specialists [19]. The value of an education-focused inter-
vention for GPs in Parma LHA was supported by a pre-
intervention survey that identified knowledge gaps regarding
PIM prescribing for older adults [20]. In prior studies of the
intervention’s association with changes in PIM use, we found
the proportion of older adults exposed to PIMs declined
31.4% from the pre-intervention period (7.8%) to the inter-
vention period (5.3%) [15], and the lower prevalence of PIM
exposure was sustained even after the intervention’s termin-
ation [18]. However, it remains to be seen whether our inter-
vention was associated with a decrease in hospitalizations.
Due to the known association between PIM exposure and
increased hospitalization rates [9–11], we hypothesized that
our quality improvement intervention that successfully re-
duced PIM exposure [15] led to lower unplanned
hospitalization rates. The objective of this study was to quan-
tify changes in unplanned hospitalization rates among older
adults in Parma LHA associated with a quality improvement
intervention that reduced PIM exposure.
Methods
Setting
Italy consists of a single-payer healthcare system, in
which the country is divided into 21 regional govern-
ments, and healthcare is delivered through networks of
geographically defined LHAs. Each citizen is assigned a
primary care physician or pediatrician within a specific
LHA [21]. Italian residents are not permitted to opt out
of the public system, so substitutive private coverage
does not exist, although a small fraction (~ 10%) of resi-
dents purchase complementary insurance to cover co-
payments or supplemental insurance to cover expanded
services [22].
Data source and structure
We conducted a retrospective longitudinal cohort study
for the years 2005–2014 using the administrative health-
care database of the LHA of Parma, which covers
approximately 420,000 inhabitants. The Parma LHA
healthcare administrative database is comprehensive and
includes de-identified demographic, hospital, outpatient,
and pharmacy information for all covered members and
services covered by the public system.
Study population
Residents of the Parma LHA were included in the ana-
lysis for a given quarter (Q1: January 1–March 31, Q2:
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April 1–June 30, Q3: July 1–September 30, or Q4: Octo-
ber 1–December 31) if they were alive at the start of the
quarter, were at least 65 years old at the beginning of the
quarter, and remained residents of the LHA of Parma
for the duration of the calendar year (residency data
were only available annually). Residents were followed
until death, out-migration from the LHA, long-term
hospitalization of greater than one quarter, or the end of
the study period.
Intervention
The physician-focused intervention to reduce inappro-
priate prescribing among older adults in Parma LHA
was implemented in stages from the fourth quarter of
2007 (Q4 2007) through Q4 2009. This intervention
which engaged all 303 LHA GPs, is described in detail
elsewhere [15]. In essence, the multimodal intervention
was implemented in 3 stages. The first stage (2007 Q1-
Q4) included the development of an Italian-focused
PIMs list by an expert panel. This stage ended with dis-
semination of the list, along with PIM prevalence data
for each district of Parma LHA, to GPs via email and
through educational sessions using a peer-to-peer inter-
active approach. In stage 2 (2008 Q1-Q4), the expert
panel developed an alternative list of drugs to substitute
for PIMs, which was presented to GPs along with PIM
prevalence data. In phase 3 (2009 Q1-Q4), the expert
panel developed case studies based on the most preva-
lent PIM scenarios, which were then presented to the
GPs along with PIM prevalence data [15]..
We anticipated a slight lag between the initiation of
our quality improvement intervention to reduce PIM ex-
posure, changes in prescribing practices, and the hypoth-
esized association with unplanned hospitalizations.
Reviewing the raw data confirmed our expectations and
we applied a one-year lag between the start of the inter-
vention and the beginning and end of the exposure
period to account for this delay. Therefore, older adults
were considered exposed to the PIM-focused QI initia-
tive during the period Q1 2009 to Q4 2010. The pre-
intervention period spanned Q1 2005 to Q4 2008 and
the post-intervention period spanned Q1 2011 to Q4
2014. We performed two sensitivity analyses testing a
shorter (0.5 year) and longer (1.5 years) lag period be-
tween the beginning of the quality improvement initia-
tive and the intervention’s effect on hospitalization rates.
Outcome
The primary study outcome was all-cause unplanned
hospitalizations (i.e., those that were unscheduled and
required an urgent level of care). We counted the num-
ber of individuals with an unplanned hospital admission
during each quarter of our 10-year study in which they
were at risk (alive and living in Parma LHA). To explore
one possible mechanism by which the intervention may
have reduced unplanned hospitalization rates, we also
examined a composite secondary outcome of cause-
specific hospitalizations for diagnoses representing po-
tential adverse drug events associated with non-steroidal
anti-inflammatory drugs (NSAIDs) and digoxin (Add-
itional File 1). The intervention has previously been as-
sociated with large decline in NSAID and digoxin use in
Parma, LHA [15].
Covariates
Demographic characteristics included age, sex, and geo-
graphic location (plain, hill, or mountain). In Parma
LHA, geographic location may be considered a proxy for
population density with residence in either the plains,
hills, or mountains roughly corresponding to urban, sub-
urban, and rural areas. Pharmacy outpatient data were
used to calculate the number of Chronic Condition Drug
Groups (CCDGs) in the year prior [23]. As a time-
dependent summary score for medical morbidity,
CCDGs can identify up to 31 chronic conditions; the
higher the CCDG score, the greater the number of
chronic conditions. The CCDG score has been used in
numerous studies as a comorbidity index [9, 24–26]. For
the analysis, the CCDG score was updated in a sliding
window every quarter.
Statistical methods
Descriptive statistics were used to summarize the char-
acteristics of the study population during the pre-
intervention, intervention, and post-intervention periods.
Crude hospitalization rates were calculated for each
period as the average of the number of hospitalizations
divided by the number of older adults at risk during
each year of the period.
Multivariable longitudinal negative binomial general-
ized estimating equations (GEE) modeling was used to
estimate trends in quarterly hospitalization rates (counts
of hospitalizations over the number of eligible older
adults) during the pre-intervention, intervention, and
post-intervention periods using a piecewise linear trun-
cated power basis spline for time. The model adjusted
for correlation within individuals and for time-
dependent and time-fixed covariates. Sex was considered
as the only time-fixed variable in the model. The time
dependent variables included: age at the start of each
quarter, yearly updated geographic location, number of
CCDGs in the previous four quarters, season, and three
spline time trend variables. Time ranged from − 15 to 24
over 40 quarters of the study period with time 0 corre-
sponding to the last quarter of the pre-intervention
period (Q4 2008). Knots, the break points in the spline
function where the pieces of the time trend were allowed
to change, were placed at time 0 and at time 8 (Q4
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2010). In the two sensitivity analyses to test a shorter
and longer lag period between the start of the interven-
tion and its effect on the outcome, the knots were
shifted backward in time by two quarters (to test a
shorter 0.5 year lag period) or forward by two quarters
(to test a 1.5 year lag period).
For presentation of results, the spline parameters
were combined to represent piecewise linear slopes
on the log rate scale so that the anti-log of those
quantities represented the expected incidence rate ra-
tio changes associated with quarterly increases in time
for each period. To estimate the number of hospitali-
zations potentially avoided by the intervention, we
contrasted model predictions for the intervention
period in the presence of the intervention (i.e., con-
sistent with data observed) and in the absence of the
intervention (i.e., projected, as though the interven-
tion never happened). To estimate the number of
hospitalizations that might have occurred absent the
intervention, the trend modeled in the pre-
intervention period was projected through the
intervention period and the expected value for
hospitalization counts was estimated and summed for
each quarter of the intervention. This value was then
compared with the number of hospitalizations for the
intervention period as predicted by the model in the
presence of the intervention (i.e., observed), and the
difference was reported as the number of hospitaliza-
tions avoided.
Taking the perspective of the Parma LHA, we applied
the median length of hospital stay values from our pa-
tient population and average cost-per-stay estimates for
hospitalizations in Italy [27] to estimate the average cost
of the hospitalizations avoided by the intervention dur-
ing the intervention period. The average cost per in-
patient bed day of a hospitalization in Italy has been
estimated to be $506 (2010 USD; not including drug
costs) [27], and the median length of stay in our patient
population was 8 days. Therefore, each hospitalization
was estimated to cost $4048.
Results
The study population included 151,747 older adults cor-
responding to 973,927 person-years, of which 382,710
person-years (39.3%) were contributed to the pre-
intervention period, 193,901 person-years (19.9%) to the
intervention period, and 397,316 person-years (41%) to
the post-intervention period. The majority of person-
time was contributed by women, older adults ages 65–
74 years, residents of plains regions, and those with 4 or
more chronic conditions (Table 1). The fraction of
person-time contributed by adults with 4 or more
chronic conditions was 74.2% in the pre-intervention
compared with 78.8% during the intervention and 79.6%
post-intervention.
Table 1 Characteristics of Older Adults in Parma LHA (N = 151,747) during the Pre-Intervention, Intervention, and Post-Intervention
Periods
Pre-Intervention
Q1 2005 – Q4 2008
Intervention
Q1 2009 – Q4 2010
Post-Intervention
Q1 2011 – Q4 2014
Number of Residents 117,061 107,347 121,871
Person-Years Contributed 382,710 193,901 397,316
Age Groups (%)a
65–74 49.2 48.5 47.8
75–84 37.1 36 35.8
85+ 13.7 15.5 16.4
Sex (%)a
Women 58.8 58.3 57.7
Geographic Location (%)a
Hill 31.1 31.2 31.6
Mountain 10.6 10.3 10
Plain 58.3 58.5 58.4
Number of Chronic Conditions (%)a
0 11.9 10.2 10.2
1–3 13.8 11 10.2
4+ 74.2 78.8 79.6
Hospitalizations per 1000 person-years 146.2 146.8 140.8
aPercentage represents proportion of person-years contributed
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Crude hospitalization rates for the pre-intervention,
intervention, and post-intervention periods were 146.2
(95% CI: 142.2–150.3), 146.8 (95% CI: 143.6–150.0), and
140.8 (95% CI: 136.9–144.7) hospitalizations per 1000
persons per year, respectively. Crude hospitalization
rates began increasing in the 2 years preceding the inter-
vention period and then decreased during the interven-
tion before increasing and leveling off during the post-
intervention period (Fig. 1).
After adjusting for demographic characteristics, the
pre-intervention hospitalization rate was estimated to
have been declining by 0.7% each quarter (IRR = 0.993;
95% CI 0.991–0.995). Hospitalization rates during the
intervention were estimated to have been declining by
1.8% each quarter (IRR = 0.982; 95% CI 0.979–0.985).
Post-intervention hospitalization rates were estimated to
have been declining by 0.1% each quarter (IRR = 0.999;
95% CI 0.997–1.001; Table 2). Associations were consist-
ent in sensitivity analyses testing a shorter and longer
lag period between the start of the intervention and its
effect on hospitalization rates (Additional File 2). The as-
sociation between the intervention period and the sec-
ondary composite outcome of potential NSAID and
digoxin cause-specific hospitalizations was directionally
consistent but weaker than the association with the pri-
mary outcome (Additional File 3).
Associations between covariates and hospitalization
rates are presented in Addtional File 4. The hospitalization
rate was 30% lower among women (IRR: 0.700; 95% CI:
0.688–0.711), while each one-year increase in age was
associated with a 6.4% higher (IRR: 1.064; 95% CI: 1.063–
1.065) hospitalization rate.
Extrapolating the pre-intervention trend through the
intervention period, an estimated 31,261 unplanned hos-
pitalizations would have occurred absent the interven-
tion. In the presence of the intervention, an estimated
29,780 unplanned hospitalizations occurred during the
intervention period. Therefore, an estimated 1481 un-
planned hospitalizations may have been avoided by the
intervention. Applying the average cost of $4048 per un-
planned hospitalization, our analyses suggest a potential
savings of $5,995,088 from avoiding these unplanned
hospitalizations over the 2 years of the intervention.
Discussion
A regional physician-focused quality improvement initia-
tive that successfully reduced PIM utilization was associ-
ated with the acceleration of a pre-existing trend of
declining unplanned hospitalization rates among older
adults in Parma LHA. The estimated avoidance of al-
most 1500 unplanned hospitalizations during the short
two-year intervention period suggests the intervention
may have led to clinically meaningful benefits to resi-
dents and substantial cost-savings of almost $6,000,000
to the healthcare system. In the context of an aging
population and an increasing burden of multimorbidity
in our population and internationally, these findings
underscore the central role that appropriate medication
management continues to play in the prevention of ser-
ious adverse events for high-risk older adults. As
Fig. 1 Crude Hospitalizations Rates during the Pre-Intervention, Intervention, and Post-Intervention Periods. aThe quality improvement initiative
was implemented in stages beginning in the fourth quarter (Q4) of 2007 and ending in 2009 (Q4). The beginning and end of the intervention
period reflects a one-year lag from the start and end of the intervention
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healthcare systems are increasingly held accountable for
the quality and cost of care delivered, investment in
system-level prescriber focused interventions to reduce
PIM use among older adults should be considered by
policymakers and organizational leaders as a promising
avenue towards achieving these dual objectives.
Although the hospitalization rate leveled off after the
intervention period, absence of an increasing trend post-
intervention suggests that PIM prescribing practices did
not revert to baseline levels, consistent with prior evalu-
ation of the intervention’s long-term effect on PIM use
[18]. The deceleration of the rate of decline in hospitali-
zations was likely the result of a few factors. Declining
PIM use inherently presents fewer opportunities to
intervene. Furthermore, individual PIMs and classes of
PIMs vary substantially in the magnitude of increased
hospitalization risk associated with exposure [9–11], and
the ease with which deprescribing barriers can be over-
come [28]. Once providers made initial changes in their
clinical practice to reduce exposure to the most danger-
ous and most easily substituted medications, diminishing
marginal returns can be expected as only PIMs deemed
relatively less dangerous or difficult to avoid would re-
main as potential targets for regimen modification.
There is growing evidence to support an association
between PIM exposure and hospitalization in older
adults [9–11]. However, there has been relatively little
research exploring the relationship between interven-
tions to reduce PIM use in older adults and
hospitalization rates. A 2015 review [16] identified 5
studies focused on interventions to improve polyphar-
macy in older individuals that also included hospitaliza-
tions as an outcome measure [29–33]. Previous studies
have varied in structure and outcomes measured. The
majority were focused on the effects of integrating a
pharmacist into the healthcare team [30–33] and other
interventions included incorporating medication reviews
using explicit criteria [29], and implementation of a
medication therapy management program [33]. Results
of a recent meta-analysis of randomized controlled trials
support the effectiveness of this type of pharmacist-led
intervention. The odds of adverse drug reactions among
older adults exposed to pharmacist-led interventions
were 21% lower and the odds of serious adverse drug re-
actions were 36% lower than control arms [17].
To the best of our knowledge, the quality improve-
ment initiative in Parma LHA was the first multiphase,
multimodal educational outreach intervention targeting
PIM reduction that has been delivered and evaluated at
the level of an entire local health system. In contrast to
most prior studies of PIM focused interventions which
modified workflow and team structure within a limited
clinical context, our study estimated changes in un-
planned hospitalization rates for the full population of
over 100,000 older adults residing in Parma LHA. Al-
though the multifaceted nature of the intervention pre-
cludes estimation of effects for specific components,
individual components have been previously examined.
Studies of educational outreach visits (i.e., academic de-
tailing) have reported small but consistent effects on
prescribing, with mixed results for studies comparing
educational visits delivered to individuals versus groups
[34]. Continuing education meetings and workshops
have also been found to precipitate small but potentially
meaningful changes in clinical practice [35], with larger
effects observed for interventions that involve interactive
components, as was the case in Parma LHA. However,
most earlier studies have stopped short of establishing a
connection between changes in prescribing and health
outcomes such as hospitalization.
Limitations of the present study stem primarily from
the absence of a contemporary comparison group that
was unexposed to the intervention. Although other secu-
lar changes affecting hospitalization rates during the
intervention period cannot be excluded as potential con-
founders, no other system-wide interventions to reduce
hospitalization rates were implemented in Parma LHA
during the intervention period. Although we adjusted for
the increasing age and morbidity burden observed in
later time periods in our study, which led to the differ-
ences between crude and adjusted trends, the direction
of residual confounding associated with the aging of the
population is expected to bias results against an associ-
ation with the intervention. Other secular trends in-
cluded seasonal fluctuations in influenza severity and
increases in socioeconomic stress associated with the
economic recession that began in 2008. In the case of
the former, influenza severity among older adults in the
neighboring region of Lombardy, Italy, was greatest dur-
ing the post-intervention period (2011–2014) [36]. The
economic recession in Italy was most severe during the
Table 2 Association between a Quality Improvement Initiative
to Reduce PIM Use and Quarterly Unplanned Hospitalization
Rates
Estimatea IRRa (95% CI)
Time (per quarter)b
Pre-Intervention −0.007 0.993 (0.991, 0.995)
Intervention −0.018 0.982 (0.979, 0.985)
Post-Intervention −0.001 0.999 (0.997, 1.001)
aEstimates and incidence rate ratios for quarterly changes in unplanned
hospitalization rates during the specified time period from a multivariable
longitudinal negative binomial GEE model
bTime represented in the model as the piecewise linear truncated power basis
spline. The pre-intervention, intervention, and post-intervention estimates
were calculated from the linear combination of coefficients for three time
trend variables
IRR Incidence Rate Ratio, CI Confidence Interval, PIM potentially
inappropriate medication
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latter years of our study period (2012–2014) [37], and
has been associated with increases in unhealthy behav-
iors [38] and increases in hospitalizations for myocardial
infarction [39].
The selection of the lag period (one-year) represents a
potential limitation, as the onset of the PIM education
initiative’s effects on hospitalizations may have begun
before 1 year into the intervnetion and may have contin-
ued beyond 1 year after the end of the initiative. After
adjusting for increasing age and medical morbidity over
time, hospitalization rates were declining during the pre-
intervention period, and it is possible the first phase of
the intervention (Q42007 to Q4 2008) contributed to
this trend. Additionally, we studied changes in the rates
of all-cause unplanned hospitalizations because of the
low sensitivity with which iatrogenic hospitalizations can
be identified using administrative data. Therefore, we
were unable to distinguish between changes in PIM-
induced hospitalizations and hospitalizations not caused
by PIMs. Finally, our estimates of unplanned hospitaliza-
tions avoided and savings as a result of hospitalizations
avoided are crude estimates and do not consider the cost
of implementing the intervention. Our cost estimate was
from the perspective of the LHA of Parma, where the
cost of a hospitalization is on average half that of a
hospitalization in the United States [27, 40]. Therefore,
the cost savings associated with a similar number of hos-
pitalizations avoided by a US based (or other high-cost)
health system would be much larger.
Our study was conducted in a single LHA in Italy, but
can reasonably be expected to be generalizable to other
parts of the country. Other health systems considering a
prescriber-focused intervention to reduce PIM use and
associated hospitalizations should consider factors such
as the baseline levels of PIM use and prescriber know-
ledge gaps to understand the size of the potential oppor-
tunity for improvement associated with such an
intervention. Furthermore, an important component of
our intervention’s success in Parma LHA was the high
levels of engagement from the provider community. This
was facilitated by the inclusion of GPs in the design and
implementation of the intervention, as well as by the GP
centric nature and single payer structure of the Italian
health system. Other health system leaders should evalu-
ate the appropriate targets (e.g., GPs, specialists) and
consider the extent to which strong provider engage-
ment is likely within their own local context. Beyond in-
terventions targeting prescribers, educating patients
regarding the risks of PIM use can increase motivation
to deprescribe hazardous drugs and should be consid-
ered as another mechanism for reducing PIM use [41].
A majority of older adults would like to reduce the num-
ber of medications they are taking [42]. Further research
is needed to understand the extent to which multimodal
interventions that simultaneously target both patients
and prescribers could produce synergistic reductions in
rates of PIM exposure and associated adverse events.
Conclusion
To date, our analysis is the first that has attempted to es-
timate the relationship between a multifaceted local
health system wide general practitioner focused inter-
vention to reduce PIMs and changes in unplanned
hospitalization rates among a locality’s older adult popu-
lation. Our research suggests that interventions to re-
duce PIMs in older adults can also decrease unplanned
hospitalization rates. This reduction was found to be the
most pronounced during the time period of the inter-
vention, presumably yielding clinical benefits for the pa-
tients, as well as economic savings for Parma LHA. In
the face of aging populations and escalating health care
costs, multimodal educational outreach interventions to
reduce PIM exposure hold promise for health systems
seeking to improve health outcomes and reduce the
utilization of high-cost inpatient care.
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